English – Page 92 – TechStock²

Honeywell stock flat as new Google Cloud retail tech lands, Citi trims target ahead of earnings

New York, Jan 12, 2026, 15:00 EST — Regular session Shares of Honeywell International Inc (HON.O) ticked up roughly 0.1% to $207.5 in Monday afternoon trading, as investors digested the company’s latest product launches targeting retailers and warehouse operators. The

12 January 2026

Earnings Reports·Investment Analysis·Retail Industry·Stock Market·Technology News

D.R. Horton stock rises as KBW trims target — what Wall Street is watching next

NEW YORK, Jan 12, 2026, 15:07 (ET) — Regular session D.R. Horton’s shares edged up roughly 1% to $158.82 Monday afternoon, even as Keefe Bruyette & Woods lowered its price target on the homebuilder. The firm cut the target to

12 January 2026

Financial News·Investing·Real Estate·Stock Market·Wall Street

SoFi stock slides as CEO Anthony Noto weighs Trump’s 10% credit-card rate cap

New York, January 12, 2026, 14:50 EST — Regular session Shares of SoFi Technologies (SOFI.O) dropped 2.4% to $26.74 in afternoon trading Monday, wiping out earlier gains. The slide came after CEO Anthony Noto highlighted potential growth in personal loans

12 January 2026

Financial News·Interest Rates·Stock Market

Nike stock dips even after Jefferies’ “buy aggressively” call — what NKE investors are watching next

New York, Jan 12, 2026, 14:43 EST — Regular session Nike shares dropped 0.6% to $65.52 in Monday afternoon trading, despite Jefferies reaffirming its buy rating and naming the sportswear giant its top large-cap pick for 2026. Analyst Randal Konik

12 January 2026

Financial News·Investing·Market Trends·Nike·Stock Market

Lemonade stock hits fresh 52-week high as LMND rallies; traders watch short interest and earnings

New York, January 12, 2026, 14:55 (ET) — Regular session Lemonade Inc shares surged 7.7% to $85.81 on Monday, pushing higher amid a wave of buying in volatile growth stocks. Earlier in the day, the online insurer’s stock hit $85.99.

12 January 2026

Earnings Reports·Financial News·Investing·Stock Market·Trading Strategies

Verizon stock slips in regular trade as ex-dividend date hits, earnings loom

New York, Jan 12, 2026, 14:22 EST — Regular session Verizon Communications Inc shares slipped 1.6% to $39.81 by Monday afternoon, following a Friday close of $40.46. During the session, the stock fluctuated between $39.52 and $40.08, with roughly 18.7

12 January 2026

Dividend News·Earnings Reports·Investment Analysis·Stock Market

Sarepta stock sinks as Elevidys sales miss, flu delays spill into 2026

New York, Jan 12, 2026, 14:53 EST — Regular session. Sarepta Therapeutics shares dropped roughly 13% to $20.73 in Monday afternoon trading following a disappointing sales forecast for its Duchenne muscular dystrophy gene therapy, Elevidys, in the fourth quarter. This

12 January 2026

Biotech Stocks·Investment Insights·Market Analysis·Pharmaceutical News

Abercrombie & Fitch stock slides 17% after outlook trim puts tariffs back on the tape

NEW YORK, Jan 12, 2026, 14:43 EST — Regular session Shares of Abercrombie & Fitch Co dropped 17.3% to $103.26 in afternoon trading Monday, following a cut to its full-year sales growth forecast and a more cautious holiday-quarter outlook. The

12 January 2026

Economic News·Financial Analysis·Retail Industry·Stock Market

Merck (MRK) stock slides as JPMorgan conference tests deal buzz and vaccine risk

New York, January 12, 2026, 14:42 EST — Regular session. Merck & Co shares slipped $1.26, or 1.1%, to $109.27 in Monday afternoon trading. The stock has fluctuated between $111.45 and $108.95 today. Investors want clarity on Merck’s next steps

12 January 2026

Financial Analysis·Healthcare Industry·Investment News·Pharmaceuticals·Stock Market

Goldman Sachs stock ticks up as Powell probe threat, rate-cap talk keep banks on edge

New York, Jan 12, 2026, 14:29 (EST) — Regular session The Goldman Sachs Group, Inc. (GS) shares climbed 0.6% to $944.73 in Monday’s afternoon trading. So far, the stock has fluctuated between $927.40 and $945.86 during the session. Investors are

12 January 2026

Banking·Federal Reserve·Financial News·Interest Rates·Stock Market

Nuvation Bio stock slides nearly 18% as Eisai deal, early IBTROZI sales hit screens

New York, Jan 12, 2026, 14:44 ET — Regular session underway Nuvation Bio Inc shares tumbled almost 18% on Monday following news of a licensing deal with Japan’s Eisai and initial sales data for its lung-cancer treatment. The stock slipped

12 January 2026

Biotechnology·Earnings Reports·Investment News·Stock Market

Apellis (APLS) stock slides 15% after $689 mln 2025 revenue preview at JPM conference

New York, Jan 12, 2026, 14:41 EST — Regular session Apellis Pharmaceuticals shares dropped almost 15% Monday following the release of preliminary 2025 U.S. sales numbers ahead of its J.P. Morgan Healthcare Conference update. The move put the stock in

12 January 2026

Earnings Reports·Financial Analysis·Investment News·Pharma Industry·Stock Market